Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-08-16
2005-08-16
Gitomer, Ralph (Department: 1651)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S021800
Reexamination Certificate
active
06930090
ABSTRACT:
The present invention relates to amphiphilic drug-oligomer conjugates capable of traversing the blood-brain barrier (“BBB”) and to methods of making and using such conjugates. An amphiphilic drug-oligomer conjugate comprises a therapeutic compound conjugated to an oligomer, wherein the oligomer comprises a lipophilic moiety coupled to a hydrophilic moiety. The conjugates of the invention further comprise therapeutic agents such as proteins, peptides, nucleosides, nucleotides, antiviral agents, antineoplastic agents, antibiotics, etc., and prodrugs, precursors, derivatives and intermediates thereof, chemically coupled to amphiphilic oligomers.
REFERENCES:
patent: 3256153 (1966-06-01), Heimlich
patent: 4003792 (1977-01-01), Mills et al.
patent: 4044196 (1977-08-01), Hüper et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4410547 (1983-10-01), Ueno et al.
patent: 4585754 (1986-04-01), Meisner et al.
patent: 4622392 (1986-11-01), Hong et al.
patent: 4684524 (1987-08-01), Eckenhoff et al.
patent: 4698264 (1987-10-01), Steinke
patent: 4717566 (1988-01-01), Eckenhoff et al.
patent: 4744976 (1988-05-01), Snipes et al.
patent: 4772471 (1988-09-01), Vanlerberghe et al.
patent: 4797288 (1989-01-01), Sharma et al.
patent: 4840799 (1989-06-01), Appelgren et al.
patent: 4849405 (1989-07-01), Ecanow
patent: 4935246 (1990-06-01), Ahrens
patent: 4939174 (1990-07-01), Shashoua
patent: 4963367 (1990-10-01), Ecanow
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5055300 (1991-10-01), Gupta
patent: 5055304 (1991-10-01), Makino et al.
patent: 5061691 (1991-10-01), Yagi et al.
patent: 5093198 (1992-03-01), Speaker et al.
patent: 5286637 (1994-02-01), Veronese et al.
patent: 5428128 (1995-06-01), Mensi-Fattohi et al.
patent: 5539063 (1996-07-01), Hakimi et al.
patent: 5545719 (1996-08-01), Shashoua et al.
patent: 5559213 (1996-09-01), Hakimi et al.
patent: 5595732 (1997-01-01), Hakimi et al.
patent: 5602099 (1997-02-01), Schiller
patent: 5631263 (1997-05-01), Portoghese et al.
patent: 5641861 (1997-06-01), Dooley et al.
patent: 5653987 (1997-08-01), Modi et al.
patent: 5663295 (1997-09-01), Moreau et al.
patent: 5681811 (1997-10-01), Ekwuribe
patent: 5693769 (1997-12-01), Kahne et al.
patent: 5747646 (1998-05-01), Hakimi et al.
patent: 5786447 (1998-07-01), Schiller et al.
patent: 5792834 (1998-08-01), Hakimi et al.
patent: 5932462 (1999-08-01), Harris et al.
patent: 6030941 (2000-02-01), Summerton et al.
patent: 6191105 (2001-02-01), Ekwuribe et al.
patent: 6309633 (2001-10-01), Ekwuribe et al.
patent: 6440933 (2002-08-01), Bodor et al.
patent: 6638906 (2003-10-01), Ekwuribe
patent: 6703381 (2004-03-01), Ekwuribe et al.
patent: 6713452 (2004-03-01), Ekwuribe et al.
patent: 6770625 (2004-08-01), Soltero et al.
patent: 6828305 (2004-12-01), Ekwuribe et al.
patent: 6858580 (2005-02-01), Ekwuribe et al.
patent: 2003/0228275 (2003-12-01), Ekwuribe et al.
patent: 2004/0102381 (2004-05-01), Ekwuribe et al.
patent: 2004/0180840 (2004-09-01), Ekwuribe et al.
Delgado et al. “The Uses and Properties of PEG-Linked Proteins”.Critical Review in Therapeutic Drug Carrier Systems, 9(3, 4):249-304 (1992).
Sakane, Toshiyasu, et al., “Carboxyl-directed Pegylation of Brain-derived Neurotrophic Factor Markedly Reduces Systemic Clearance with Minimal Loss of Biologic Activity,”Pharmaceutical Research, vol. 14, No. 8, pp. 1085-1091, 1997.
Anderson et al. “Structure-Activity Relationship Assessment of Conjugated Enkephalins in Centrally Mediated Analgesia”Soc. Neurosci. Abstr. 25(1):180 (1999).
Anderson Jr. Wes
Ansari Aslam M.
Ekwuribe Nnochiri N.
Price Christopher H.
Radhakrishnan Balasingam
Barrett William A.
Gitomer Ralph
Moore & Van Allen PLLC
Nobex Corporation
LandOfFree
Methods of activating a receptor using amphiphilic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of activating a receptor using amphiphilic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of activating a receptor using amphiphilic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3508936